1 / 5

Insulin Delivery Devices Market Growth Potential with Staggering CAGR Value by 2025

Download Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPHE100000819<br><br>Global insulin delivery devices market accounted to US$ 11,869.0 Mn in 2017 and is expected to grow at a CAGR of 8.7% during the forecast period 2018 u2013 2025, to account to US$ 22,830.0 Mn by 2025.<br><br>Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and mortality in ageing population that later largely attributable to various chronic complications. Ageing population is poised to become one of the most significant transformation with a heavy impact on the social and economic level across the globe.

LindaHoward
Download Presentation

Insulin Delivery Devices Market Growth Potential with Staggering CAGR Value by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Insulin Delivery Devices Market Publication Month: Oct 2018 | Report Code: TIPHE100000819 | No. of Pages: 194 | Category: Medical Device | Status: Published Insulin Delivery Devices Market to 2025 - Global Analysis and Forecasts By Product (Insulin Pens, Insulin Pumps, Insulin Syringes, Pen Needles, and Others), End User (Patients/Homecare and Hospitals & Clinics), and Geography E-Mail : sales@theinsightpartners.com

  2. Insulin Delivery Devices Market Publication Month: Oct 2018 | Report Code: TIPHE100000819 | No. of Pages: 194 | Category: Medical Device | Status: Published Introduction: Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and mortality in ageing population that later largely attributable to various chronic complications. Ageing population is poised to become one of the most significant transformation with a heavy impact on the social and economic level across the globe. These population is growing exponentially worldwide. According to a report of United Nation (2017), there were approximately 962 million people aged 60 or over across the globe in 2017 and was projected to reach to 425 million by 2050. The global insulin delivery devices market accounted to US$ 11,869.0 Mn in 2017 and is expected to grow at a CAGR of 8.7% during the forecast period 2018 – 2025, to account to US$ 22,830.0 Mn by 2025. E-Mail : sales@theinsightpartners.com

  3. Insulin Delivery Devices Market Publication Month: Oct 2018 | Report Code: TIPHE100000819 | No. of Pages: 194 | Category: Medical Device | Status: Published Increasing Technological Advancement in Insulin Delivery Devices The increasing advancements in blood glucose (BG) monitoring technology have resulted in improved accuracy, smaller required blood volumes, and the ability to transfer data between the BG meter and insulin delivery devices. For instance, in September 2016, the FDA announced their first automatically automatic glucose monitoring device, Medtronic’s MiniMed 670G which is a hybrid closed looped system that provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. In addition, in July 2018, Abbott announced to have a FDA approval for the FreeStyleLibre 14 day Flash Glucose Monitoring system that allows people with diabetes to wear the sensor up to 14 days with high accuracy. These advancements are expected to offer increasing demand for the products, hence providing better share to the market players. Product Insights The global insulin delivery devices market by product was led by insulin pens segment. In 2017, the insulin pens segment held a largest market share of 31.3% of the insulin delivery devices market, by product. The segment is also expected to dominate the market in 2025, since they offer increasing ease of use; increasing patient satisfaction and adherence; accuracy for delivering small doses of insulin. End User Insights The insulin delivery devices market by end user was segmented into patients/homecare and hospitals & clinics. The patients/homecare segment held the largest share of the market, by end user. The segment is also likely to dominate during the forecast period, as it allows a patient to regulate as well as monitor the glucose levels as well as administer insulin at home. E-Mail : sales@theinsightpartners.com

  4. Insulin Delivery Devices Market Publication Month: Oct 2018 | Report Code: TIPHE100000819 | No. of Pages: 194 | Category: Medical Device | Status: Published • INSULIN DELIVERY DEVICES - MARKET SEGMENTATION • By Product • Insulin Pens • Reusable Insulin Pens • Disposable Insulin Pens • Insulin Pumps • Tube Pumps • Patch Pumps • Insulin Syringes • Pen Needles • Standard Pen Needles • Safety Pen Needles • Others • By End User • Patients/Homecare • Hospitals & Clinics E-Mail : sales@theinsightpartners.com

  5. Insulin Delivery Devices Market Publication Month: Oct 2018 | Report Code: TIPHE100000819 | No. of Pages: 194 | Category: Medical Device | Status: Published • The List of Companies • BD • Novo Nordisk A/S • B. Braun Melsungen AG • Insulet Corporation • Medtronic • Tandem Diabetes Care, Inc. • Eli Lilly and Company • Biocon • Owen Mumford, Ltd. • Sanofi Get Sample Brochure E-Mail : sales@theinsightpartners.com

More Related